Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglaite Injection in advanced NSCLC
NCT03986528Phase 4Unknown
- Start
- Aug 2019
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
A Phase 4 trial of kanglaite in non-small cell lung cancer (NSCLC). Status: unknown.
02
Drugs
kanglaite
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03986528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03986528.